Thomas Ming Swi Chang
Artificial cells; bioencapsulation used in nanomedicine; blood substitutes; cancer therapy; cell and stem cell therapy; cellular engineering; COVID mRNA vaccines; drug delivery; hemoperfusion; hereditary enzyme defects such as phdnylketonuia and nanobiotherapeutic; nanoparticles; synthetic cells; tissue engineering.